News

BioSpace4h
RFK Jr. Joins Deputies in Voicing Support for Regulatory Flexibility for Cell and Gene Therapies
In a roundtable event on Thursday, HHS Secretary Robert F. Kennedy Jr. said his office will work to eliminate barriers that ...
BioSpace3h
Perspective Therapeutics Brings Energy to the Radiopharma World
The Seattle-based company came to ASCO25 with new data on its neuroendocrine tumor–treating lead therapy, with big vibes and ...
BioSpace3h
Otsuka Sees ‘Impressive’ Proteinuria Reduction in Phase III IgAN Trial
Otsuka's investigational antibody sibeprenlimab approximately halved levels of this key biomarker in patients with ...
BioSpace3h
EU Regulators Confirm Rare Vision Loss Risk for Novo’s Semaglutide
Given the evidence, the committee has recommended that the labels for Novo Nordisk’s Wegovy and Ozempic be updated to include ...
BioSpace5h
Corcept Claims Survival Benefit in ALS Despite Missed Endpoint
Analysts at Truist Securities called the mid-stage data a "mixed bag," also flagging gastrointestinal adverse events. However ...
BioSpace23h
Regenxbio Fails To Best Sarepta’s Elevidys With New Data for DMD Gene Therapy
Interim results from a small group of children in a Phase I/II trial are essentially in line with that of Elevidys, according ...
BioSpace22h
uniQure’s Regulatory Progress Sparks Optimism for ‘Desperate’ Huntington’s Space
Analysts reacted positively to the news that uniQure is in alignment with the FDA on an accelerated approval pathway and on ...
BioSpace4h
Desperate Times, Desperate Measures? RFK’s Vaccine Campaign Only Breeds More Distrust
Vaccine skepticism is at an all-time high in the U.S., and HHS Secretary Robert F. Kennedy Jr. is making some drastic moves in the name of reversing that trend. But misinformation and inconsistencies ...